Zobrazeno 1 - 10
of 19
pro vyhledávání: '"59"'
Autor:
Elvira Buxó, Miguel Caballero, Paula Mackers, José Luis Blanch, Òscar Reig, Juan J. Grau, Pilar Navarrete
Publikováno v:
Oncology. 93:75-82
Objectives: To analyze the role of audiometry in considering change to a less ototoxic treatment in head and neck cancer (HNC) patients. Methods: Consecutive patients prescribed high-dose cisplatin (100 mg/m2) between January 2013 and February 2015 w
Autor:
Gaetano Facchini, Sabrina Chiara Cecere, Giampaolo De Palma, Carmela Pisano, Laura Arenare, Sandro Pignata, Stefano Greggi, Piera Gargiulo, Chiara Della Pepa, Rosa Tambaro, Marilena Di Napoli, Cono Scaffa, Sara Falivene
Publikováno v:
Oncology. 90:29-35
Objective: The aim of this study was to analyze the long-term toxicity and quality of life (QOL) in patients with locally advanced cervical cancer (LACC) treated with chemoradiation [chemotherapy/radiotherapy (CT/RT)] or neoadjuvant CT (NACT) followe
Autor:
Brent Evans, Richard J. Wenstrup, Kelsey Moyes, Krystal Brown, Michelle Landon, Jennifer Saam
Publikováno v:
Oncology. 89:221-226
Objective: Patients diagnosed with colorectal cancer before the age of 50 years are recommended for Lynch syndrome (LS) testing according to current clinical guidelines. However, many patients are not identified because of the stringent guidelines on
Autor:
Daniel Vallböhmer, Leila Sisic, Markus W. Büchler, S Kraus, Susanne Blank, Katja Ott, Nikolas H. Stoecklein, Wolfram T. Knoefel
Publikováno v:
Oncology Research and Treatment. 37:97-104
Background: Multimodality treatment options in locally advanced adenocarcinomas of the esophagogastric junction (AEGs) have been established in the last years. However, the therapeutic approach in patients with clinically staged cT2 tumors remains co
Autor:
Vincenzo Adamo, Mariangela Zanghì, Sergio Rizzo, Giuseppina Rosaria Rita Ricciardi, Antonio Russo, Giuseppa Ferraro, Tindara Franchina, Giuseppe Cicero, N. Caristi, Rosalba Rossello, Barbara Adamo
Publikováno v:
Oncology. 86:16-21
Background: Breast cancer in the elderly is associated with high recurrence and death rates, due mostly to undertreatment. Human epidermal growth factor receptor type 2 (HER2) overexpression is infrequent in older patients. Trastuzumab-based chemothe
Autor:
Samantha Aeckerle, Dieter Buchheidt, Wolf-Karsten Hofmann, Ralf-Dieter Hofheinz, Lothar R. Pilz, Deniz Gencer, Marina Moor
Publikováno v:
Oncology Research and Treatment. 36:642-648
Background: Limited clinical data have been published on patients suffering from advanced gynaecological malignancies treated in palliative care units, and little is known about prognostic factors. Methods: In a retrospective study, the data of 225 p
Autor:
Nil Molinas Mandel, Deniz Tural, Gokhan Demir, Suayip Yalçın, Fatih Selcukbiricik, Gulen Dogusoy, Sibel Erdamar
Publikováno v:
Oncology Research and Treatment. 36:18-24
Background: Gastrointestinal stromal tumors (GIST) are rare tumors of the gastrointestinal system. The most common primary site of GIST is the stomach. The treatment is primarily surgery, and the standard medical therapy is imatinib. Long-term surviv
Autor:
Michiko Iwasaki, Elizabeth Garrett-Mayer, F. L. Deaton, Manal M. Hassan, James L. Abbruzzese, Lianchun Xiao, Ahmed Kaseb, Matthew B. Thomas, Georgiana Onicescu, Hesham M. Hassabo, E. Lin, Jeffrey S. Morris
Publikováno v:
Oncology. 82:67-74
Objective: A phase II study was performed to evaluate the efficacy and tolerability of bevacizumab and erlotinib in advanced hepatocellular carcinoma (HCC) patients, and to investigate clinical and molecular predictors of outcome. Methods: 59 patient
Autor:
Sang Joon Shin, Ki Yeol Kim, Hyo Song Kim, Hyun Cheol Chung, Sun Young Rha, Joong Bae Ahn, Min Hee Hong, Hei Chul Jeung, Se-Hoon Lee, Yung-Jue Bang, Youngil Koh
Publikováno v:
Oncology. 80:395-405
Objective: We aimed to describe the efficacy and safety of sunitinib in unselected Korean advanced renal cell carcinoma (RCC) patients. Patients and Methods: From November 2005 to August 2008, 132 histologically confirmed advanced RCC patients (100 i
Publikováno v:
Urologia Internationalis. 81:320-324
Objective: To investigate the clinical significance of E-cadherin (E-CD) expression in human bladder transitional cell carcinoma (TCC) tissue and soluble forms of E-cadherin (sE-CD) in the urine of patients with TCC. Materials and Methods: One hundre